Cargando…
Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk
The conclusion of the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk was inconsistent. This study was performed to assess the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk using meta-an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762057/ https://www.ncbi.nlm.nih.gov/pubmed/28593813 http://dx.doi.org/10.1177/1533034617712396 |
_version_ | 1783291626571956224 |
---|---|
author | Zhou, Jia-Quan Kang, Xin-Li Wang, Yang Xu, Cong-Jie |
author_facet | Zhou, Jia-Quan Kang, Xin-Li Wang, Yang Xu, Cong-Jie |
author_sort | Zhou, Jia-Quan |
collection | PubMed |
description | The conclusion of the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk was inconsistent. This study was performed to assess the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk using meta-analysis. The association studies were identified from PubMed, Embase, and Web of Science, and eligible studies were included and calculated. Ten studies were included for this meta-analysis. vascular endothelial growth factor (VEGF) +405G > CC allele and GG genotype were associated with renal cell carcinoma risk for overall populations in this meta-analysis (C allele: odds ratio = 1.18, 95% confidence interval: 1.05-1.33, P = .004; CC genotype: odds ratio = 1.20, 95% confidence interval: 0.96-1.50, P = .12; GG genotype: odds ratio = 0.79, 95% confidence interval: 0.67-0.93, P = .004). Furthermore, VEGF +936C>T gene polymorphism and VEGF −2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations (+936C>T: T allele: odds ratio = 1.16, 95% confidence interval: 1.05-1.29, P = .004; TT genotype: odds ratio = 1.25, 95% confidence interval: 1.02-1.52, P = .03; CC genotype: odds ratio = 0.86, 95% confidence interval: 0.75-0.98, P = .03; −2578 C>A: A allele: odds ratio = 1.26, 95% confidence interval: 1.15-1.38, P < .00001; AA genotype: odds ratio = 1.39, 95% confidence interval: 1.16-1.67, P = .0004; CC genotype: odds ratio = 0.75, 95% confidence interval: 0.61-0.92, P = .006). However, VEGF −634G>C, VEGF −460T>C, VEGF −1154 G>A, and VEGF +1612 G>A gene polymorphisms were not associated with renal cell carcinoma risk. In conclusion, VEGF +405G>CC allele and GG genotype, VEGF +936C>T gene polymorphism, and VEGF −2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations. However, more studies should be performed to assess this relationship in the future. |
format | Online Article Text |
id | pubmed-5762057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-57620572018-01-17 Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk Zhou, Jia-Quan Kang, Xin-Li Wang, Yang Xu, Cong-Jie Technol Cancer Res Treat Original Articles The conclusion of the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk was inconsistent. This study was performed to assess the relationship between vascular endothelial growth factor gene polymorphism and renal cell carcinoma risk using meta-analysis. The association studies were identified from PubMed, Embase, and Web of Science, and eligible studies were included and calculated. Ten studies were included for this meta-analysis. vascular endothelial growth factor (VEGF) +405G > CC allele and GG genotype were associated with renal cell carcinoma risk for overall populations in this meta-analysis (C allele: odds ratio = 1.18, 95% confidence interval: 1.05-1.33, P = .004; CC genotype: odds ratio = 1.20, 95% confidence interval: 0.96-1.50, P = .12; GG genotype: odds ratio = 0.79, 95% confidence interval: 0.67-0.93, P = .004). Furthermore, VEGF +936C>T gene polymorphism and VEGF −2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations (+936C>T: T allele: odds ratio = 1.16, 95% confidence interval: 1.05-1.29, P = .004; TT genotype: odds ratio = 1.25, 95% confidence interval: 1.02-1.52, P = .03; CC genotype: odds ratio = 0.86, 95% confidence interval: 0.75-0.98, P = .03; −2578 C>A: A allele: odds ratio = 1.26, 95% confidence interval: 1.15-1.38, P < .00001; AA genotype: odds ratio = 1.39, 95% confidence interval: 1.16-1.67, P = .0004; CC genotype: odds ratio = 0.75, 95% confidence interval: 0.61-0.92, P = .006). However, VEGF −634G>C, VEGF −460T>C, VEGF −1154 G>A, and VEGF +1612 G>A gene polymorphisms were not associated with renal cell carcinoma risk. In conclusion, VEGF +405G>CC allele and GG genotype, VEGF +936C>T gene polymorphism, and VEGF −2578 C>A gene polymorphism were associated with renal cell carcinoma risk for overall populations. However, more studies should be performed to assess this relationship in the future. SAGE Publications 2017-06-08 2017-12 /pmc/articles/PMC5762057/ /pubmed/28593813 http://dx.doi.org/10.1177/1533034617712396 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Articles Zhou, Jia-Quan Kang, Xin-Li Wang, Yang Xu, Cong-Jie Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk |
title | Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk |
title_full | Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk |
title_fullStr | Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk |
title_full_unstemmed | Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk |
title_short | Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk |
title_sort | association of vascular endothelial growth factor gene polymorphism with renal cell carcinoma risk |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762057/ https://www.ncbi.nlm.nih.gov/pubmed/28593813 http://dx.doi.org/10.1177/1533034617712396 |
work_keys_str_mv | AT zhoujiaquan associationofvascularendothelialgrowthfactorgenepolymorphismwithrenalcellcarcinomarisk AT kangxinli associationofvascularendothelialgrowthfactorgenepolymorphismwithrenalcellcarcinomarisk AT wangyang associationofvascularendothelialgrowthfactorgenepolymorphismwithrenalcellcarcinomarisk AT xucongjie associationofvascularendothelialgrowthfactorgenepolymorphismwithrenalcellcarcinomarisk |